International Stem Cell Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
For the six months, net loss was USD 0.011 million compared to USD 0.383 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.065 USD | -8.71% | -8.71% | +4.84% |
1st Jan change | Capi. | |
---|---|---|
+4.84% | 520K | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+47.81% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |